Trevi Therapeutics Inc (TRVI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Operating Expenses | 13,289 | 11,906 | 8,933 | 9,045 | 8,382 |
| Operating Income | -13,289 | -11,906 | -8,933 | -9,045 | -8,382 |
| Interest Expense | 1 | 1 | 4 | 3 | 153 |
| Other Income | 930 | 997 | 1,134 | 1,337 | 1,360 |
| Pre-tax Income | -12,360 | -10,910 | -7,803 | -7,711 | -7,175 |
| Income Tax | -8 | -8 | 18 | -13 | -30 |
| Net Income Continuous | -12,352 | -10,902 | -7,821 | -7,698 | -7,145 |
| Net Income | $-12,352 | $-10,902 | $-7,821 | $-7,698 | $-7,145 |
| EPS Basic Total Ops | -0.12 | -0.11 | -0.08 | -0.08 | -0.07 |
| EPS Basic Continuous Ops | -0.12 | -0.11 | -0.08 | -0.08 | -0.07 |
| EPS Diluted Total Ops | -0.12 | -0.11 | -0.08 | -0.08 | -0.07 |
| EPS Diluted Continuous Ops | -0.12 | -0.11 | -0.08 | -0.08 | -0.07 |
| EPS Diluted Before Non-Recurring Items | -0.12 | -0.11 | -0.08 | -0.08 | N/A |
| EBITDA(a) | $-13,251 | $-11,871 | $-8,898 | $-9,010 | $-8,249 |